LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 43 filers reported holding LEAP THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $3,514 | -21.3% | 10,334 | +4.2% | 0.00% | – |
Q4 2022 | $4,464 | -93.6% | 9,920 | -87.4% | 0.00% | – |
Q3 2022 | $70,000 | -21.3% | 78,627 | +1.5% | 0.00% | – |
Q2 2022 | $89,000 | -92.7% | 77,463 | -88.9% | 0.00% | – |
Q1 2022 | $1,224,000 | +25.9% | 699,354 | +133.1% | 0.00% | – |
Q4 2021 | $972,000 | +98.8% | 300,034 | +146.4% | 0.00% | – |
Q3 2021 | $489,000 | +264.9% | 121,750 | +48.7% | 0.00% | – |
Q2 2021 | $134,000 | +83.6% | 81,881 | +113.2% | 0.00% | – |
Q1 2021 | $73,000 | – | 38,409 | +426666.7% | 0.00% | – |
Q4 2020 | $0 | -100.0% | 9 | -99.9% | 0.00% | – |
Q3 2020 | $12,000 | -42.9% | 6,009 | -40.0% | 0.00% | – |
Q2 2020 | $21,000 | – | 10,009 | +76892.3% | 0.00% | – |
Q1 2020 | $0 | – | 13 | -23.5% | 0.00% | – |
Q4 2019 | $0 | – | 17 | +41.7% | 0.00% | – |
Q3 2019 | $0 | – | 12 | +33.3% | 0.00% | – |
Q2 2019 | $0 | – | 9 | -75.0% | 0.00% | – |
Q1 2019 | $0 | – | 36 | -41.0% | 0.00% | – |
Q4 2018 | $0 | -100.0% | 61 | -46.5% | 0.00% | – |
Q3 2018 | $1,000 | -66.7% | 114 | -77.2% | 0.00% | – |
Q2 2017 | $3,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 16,952,992 | $27,802,000 | 0.18% |
Opaleye Management Inc. | 540,000 | $886,000 | 0.15% |
ACT CAPITAL MANAGEMENT, LLC | 134,000 | $220,000 | 0.11% |
Artal Group S.A. | 3,000,000 | $4,920,000 | 0.10% |
HHLR ADVISORS, LTD. | 3,575,745 | $5,864,000 | 0.06% |
PLATINUM INVESTMENT MANAGEMENT LTD | 910,047 | $1,492,000 | 0.04% |
PERSONAL CFO SOLUTIONS, LLC | 78,165 | $128,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 122,401 | $201,000 | 0.02% |
Windsor Creek Advisors, LLC | 46,955 | $77,000 | 0.02% |
Golden Green, Inc. | 14,824 | $24,000 | 0.02% |